Navigation Links
China Biologic Products Announces Strong First Quarter 2009 Results

TAI'AN, Shandong, May 18 /PRNewswire-Asia-FirstCall/ -- China Biologic Products, Inc. (OTC Bulletin Board: CBPO) ("China Biologic," or the "Company"), one of the leading plasma-based pharmaceutical companies in the People's Republic of China ("PRC"), reported strong financial results for the first quarter of 2009.

    First Quarter 2009 Highlights
    -- Revenues increased 169.4% year-over-year to a record $21.1 million
    -- Gross profit increased 153.1% to $14.9 million compared to the first
       quarter of 2008, representing a gross margin of 70.6%
    -- Operating income increased 176.6%, from the first quarter 2008 to $10.1
       million, representing an operating margin of 47.6%
    -- Net income was up 87.8% year-over-year to $4.3 million, or $0.20 per
       diluted share

"We are pleased to report exceptional revenue and net income results for our first quarter of 2009 as 'The New China Biologic Products'," said Mr. Chao Ming Zhao, CEO of China Biologic Products. "During the first quarter, we completed the government approval process for the transfer of 35% equity interest in Xi'an Huitian Blood Products Co., Ltd. We recently also completed the acquisition of a 90% controlling interest in Chongqing Dalin Biologic Technologies Co., Ltd., which owns 54% of the equity interest in Qianfeng Biologic Products Co., Ltd. Both of these acquisitions combined have transformed China Biologic into the largest non-state-owned plasma-based biopharmaceutical company in China. Our first quarter results reflect the consolidation of these interests and demonstrate the potential for significant earnings power ahead."

During the first quarter of 2009, the Company achieved the following milestones:

    -- The Company's indirect majority-owned subsidiary, Shandong Taibang
       Biological Products Co. Ltd. ("Shandong Taibang") was awarded the High-
       Technology Enterpris
SOURCE China Biologic Products, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related biology technology :

1. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
2. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
3. China Medical Technologies to Participate in the Morgan Stanleys 2007 China Medical Corporate Day
4. China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd.
5. China Technology Announces New Chief Financial Officer
6. China Medical Technologies Reports First Quarter Financial Results
7. China Medical Technologies to Participate in Credit Suisses 2007 Asian Technology Conference
8. China Technology Announces Entry to the Solar Energy Sector
9. China Sky One Medical Receives $1.5 Million Government Grant to Further Develop Six New Cancer Products
10. Kiwa Bio-Tech Named Recommended Brand by the China Green Food Association
11. China Kangtai Cactus Biotech, Inc. Announces Plans for New Product Launch
Post Your Comments:
(Date:1/15/2014)... January 15, 2014 This webinar ... on nonclinical and clinical safety assessment in biosimilars. ... guide a path for biosimilar drug development, however ... of biosimilarity with regards to quality, safety and ... of biosimilar drug development and registration, development strategies ...
(Date:1/15/2014)... NC (PRWEB) January 15, 2014 ... an enhancement to its Online Web Portal for Life ... now have the ability to specify the subject matter ... nearly 50 life science sub-domains. This will help reduce ... and scientific fields, and decrease the likelihood of error. ...
(Date:1/14/2014)... Doylestown, PA (PRWEB) January 14, 2014 ... – 11 p.m. , Location: Warrington Country Club, 1360 ... Hepatitis B Foundation, the only national nonprofit organization solely ... improving the quality of life for those affected worldwide, ... 11 at Warrington Country Club in Warrington, Pa. ...
(Date:1/14/2014)... York, NY (PRWEB) January 14, 2014 ... initiated coverage of Alliqua, Inc. (OTCQB: ALQA). Alliqua ... and marketing proprietary products to serve the wound ... , In late 2012, Alliqua was restructured ... launched the company’s new strategy to become a ...
Breaking Biology Technology:Xtalks Life Sciences Webinar Examines Safety Assessment of Biosimilars 2DTS Improves Efficiency for Life Science Document Translations 2Hepatitis B Foundation to Host Annual Crystal Ball Gala 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3
... Stem cell-enriched autologous fat enables sustainable breast augmentation ... the media: For years a French company has been ... cause cancer. More than 100,000 women worldwide must now ... or carrying a "time bomb" in their bodies. Stem ...
... Biotherapeutics (OTC.BB: NWBO) (NW Bio) today announced that it will ... the Windsor Room of the Sir Francis Drake Hotel as ... emerging biotech companies held over 3 days this week in ... attendees are expected to be listening to presentations by up ...
... SEATTLE, Jan. 10, 2012  Omeros Corporation (NASDAQ: OMER ... selectively with each of GPR25, GPR32, GPR80, GPR135 and MAS1, ... unlocked by Omeros to 23, representing 30 percent of the ... unlocked by Omeros for drug development equals half of the ...
Cached Biology Technology:Silicone Scandal: Stem Cell Breast Augmentation a Safe Alternative 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 2NW Bio to Present Today at the OneMedForum SF 2012 Conference 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 2Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 3Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 4Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs 5
(Date:4/15/2014)... research published in the March/April 2014 issue of ... shows whey protein, either as a supplement combined ... or weight-maintenance diet, may provide men and women benefits ... 14 randomized controlled trials with a total of 626 ... that used whey protein to replace calories in the ...
(Date:4/14/2014)... Rican climate over the past three decades have caused ... territory,s national animal. UCLA biologists have found that not ... call has also become shorter and higher pitched. ... of integrative biology and physiology and of ecology and ... the study examined 170 male coqui frogs ( Eleutherodactylus ...
(Date:4/14/2014)... the International Space Station inside the Dragon capsule ... in-orbit food production capabilities in more ways than ... for granted, fresh food. , NASA,s Veg-01 experiment ... and performance of a new expandable plant growth ... investigation will focus on the growth and development ...
Breaking Biology News(10 mins):New meta-analysis builds on the power of whey protein for improved body composition 2New meta-analysis builds on the power of whey protein for improved body composition 3Climate change a likely culprit in coqui frog's altered calls, say UCLA biologists 2Veggie will expand fresh food production on space station 2
... -- Dangerous disease often spreads faster than it takes ... researchers at Kansas State University have developed a test ... Sanjeev Narayanan, assistant professor, and Greg Peterson, research ... pathobiology, use a device called a DNA spotted microarray ...
... Ackermann and Wolf-Dietrich Hardt, in collaboration with Michael Doebeli ... have been able to describe how random molecular processes ... a self-destructive act to generate a greater common good, ... Survival strategy The biologists investigated this ...
... relapse after renewed drug administration are typical behavioral patterns ... the brain,s reward center are directly responsible for this. ... the Institute of Mental Health (ZI) in Mannheim, the ... University of Geneva, Switzerland, in the latest issue of ...
Cached Biology News:Rapid test for pathogens developed by K-State researchers 2ETH Zurich study on salmonella self-destruction 2ETH Zurich study on salmonella self-destruction 3Cocaine: How addiction develops 2
Anti-ACTH Immunogen: Porcine ACTH conjugated to BSA. Available Date: 38566...
Goat polyclonal to BACE1 ( Abpromise for all tested applications). entrezGeneID: 23621 SwissProtID: P56817...
... Immunogen: Peptide ... encompassing the human, mouse, and ... Accession Number: NM_000314 ... Routinely evaluated by immunoblot. ...
Mouse monoclonal [MN-8C4] to zona radiata ( Abpromise for all tested applications). Antigen: Purified eggshell proteins (zona radiata proteins and small amounts of zona pellucida proteins) from ...
Biology Products: